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Abstract
Background—Physiological responses to reward and extinction are believed to represent the 
Behavioral Activation System (BAS) and Behavioral Inhibition System (BIS) constructs of 
Reinforcement Sensitivity Theory and underlie externalizing behaviors, including substance use. 
However, little research has examined these relations directly.
Methods—We assessed individuals’ cardiac pre-ejection periods (PEP) and electrodermal 
responses (EDR) during reward and extinction trials through the “Number Elimination Game” 
paradigm. Responses represented BAS and BIS, respectively. We then examined whether these 
responses provided incremental utility in the prediction of future alcohol, marijuana, and cigarette 
use.
Results—Zero-inflated Poisson (ZIP) regression models were used to examine the predictive 
utility of physiological BAS and BIS responses above and beyond previous substance use. 
Physiological responses accounted for incremental variance over previous use. Low BAS 
responses during reward predicted frequency of alcohol use at year 3. Low BAS responses during 
reward and extinction and high BIS responses during extinction predicted frequency of marijuana 
use at year 3. For cigarette use, low BAS response during extinction predicted use at year 3.
Conclusions—These findings suggest that the constructs of Reinforcement Sensitivity Theory, 
as assessed through physiology, contribute to the longitudinal maintenance of substance use.
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1. Introduction
Innate motivational systems that govern approach and avoidance behaviors have long been 
recognized (Gray, 1970). The revised Reinforcement Sensitivity Theory (RST; Gray and 
McNaughton, 2000) indicates that three interdependent neurobiological systems influence 
an individual’s responses to reinforcement. The Behavioral Activation System (BAS) guides 
approach behavior to conditioned and unconditioned reward. In contrast, the Fight-Flight-
Freezing system (FFFS) responds to cues for threat and promotes the avoidance of 
unconditioned aversive stimuli through withdrawal and freezing behavior (Gray and 
McNaughton, 2000). The Behavioral Inhibition System (BIS) serves to detect competing 
influences from environmental stimuli and resolve conflict by inhibiting ongoing action 
(McNaughton and Gray, 2002). Despite interdependence in action, these systems are 
differentially mediated; the BAS is believed to be mediated by dopaminergic pathways 
originating in the ventral tegmental area (Matthews and Gilliland, 1999), and the BIS is 
believed to be mediated by the amygdala and septo-hippocampal systems (McNaughton and 
Corr, 2004).
Self-report measures of BAS and BIS contribute to meaningful outcomes, such as various 
forms of psychopathology (Bijttebier et al., 2009; Mellick et al., 2014). Some have argued 
that abnormally high BAS activation or low BIS activation could contribute to externalizing 
behavior (Newman and Wallace, 1993; Quay, 1997). Given the importance of motivation for 
reward in the development of problematic substance use and the shared neural substrates 
between substance-based reward learning and the BAS (Dawe et al., 2004; Hyman et al., 
2006), it stands to reason that individuals with highly active BAS may be at high risk for 
substance-related problems. Consistent with this notion, there is a large literature showing 
that people who report high self-reported reinforcement sensitivity (i.e., heightened BAS 
responding) are more likely to meet criteria for substance use disorder (Hundt et al., 2008; 
Johnson et al., 2003). Although self-reported BIS has demonstrated relations with outcomes 
associated with anxiety and other internalizing conditions (Kasch et al., 2002; Mellick et al., 
2014), low BIS has demonstrated less consistent relations to substance use (Franken and 
Muris, 2006; Hundt et al., 2008).
1.1. Measuring RST Constructs via Physiological Responses
There exists a tenuous framework linking autonomic nervous system activity with RST 
constructs (Beauchaine, 2001; Fowles, 1980; Fowles, 1988; Tomaka and Palacios-Esquivel, 
1997). In a recent review of this topic, Beauchaine (2001) asserts that cardiac pre-ejection 
period (PEP) and electrodermal responding (EDR) represent BAS and BIS, respectively. 
Shortened PEP is conceptualized as a relatively “pure” measure of sympathetic nervous 
system excitation that reflects beta-adrenergic influence on the heart. According to 
Beauchaine (2001), shortened PEP is associated with approach behavior and serves as an 
index of BAS activity when assessed during the delivery of reward. In contrast, increased 
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EDR reflects cholinergic (vs. adrenergic) pathways to the skin and is unrelated to PEP. EDR 
is implicated in the affective experience of anxiety (Biederman et al., 1993; Scarpa et al., 
1997), a characteristic associated with BIS (Fowles, 1980; 1988). When assessed during 
exposure to motivational conflict (changes in reward conditions), higher EDR is believed to 
measure BIS activation (see Beauchaine, 2001).
Despite being a novel understanding of BIS/BAS, there are emerging studies examining the 
utility of the physiological assessment of RST constructs. Tomaka and Palacios-Esquivel 
(1997) measured PEP and EDR in groups of individuals participating in a reward/
punishment task. Results indicated that, as hypothesized, BAS (PEP) change scores 
increased and stabilized during the reward condition, but decreased during the punishment 
condition. While BIS (EDR) change scores were hypothesized to increase in the punishment 
condition, signaling the motivation to inhibit responses, no significant trend was identified. 
Beauchaine and colleagues (2001) also explored physiological BIS/BAS responding during 
a task of reward and extinction. Although it was hypothesized that BAS (PEP) response 
would increase during reward (as assessed through the shortening of PEP during reward 
trials), this response was markedly low for children with externalizing disorders. BIS (EDR) 
responses during extinction were not found to differentiate between children with 
externalizing disorders and comparison children.
To our knowledge, only one study has explored the physiological assessment of RST 
constructs and substance use. This is important, given that the physiological assessment of 
BIS/BAS may provide an important link between a useful theoretical approach and 
biological disorder. Incorporating prior work, Brenner and Beauchaine (2011) revised 
predictions to suggest that BAS responding during reward should be lowered in children and 
adolescents with externalizing problems including substance use. Findings indicated that 
low PEP response during reward trials was indeed identified as a predictor in multilevel 
modeling analyses of alcohol use initiation. Responding during extinction trials was not 
explored.
This omission of responses during extinction in Brenner and Beauchaine (2011) could be 
quite important. Although results from prior work have evidenced links between these RST 
systems and externalizing behaviors, as noted by Carver (2006), this work may oversimplify 
the role of the BIS/BAS in reinforcement learning. Carver has argued that responses during 
frustrative non-reward may be more heavily influenced by the BAS than by the BIS. This 
hypothesis is based on a series of studies showing that under conditions of frustrative non-
reward (i.e., participants were led to believe they could earn a reward but then failed to do 
so), negative affective responding (i.e., frustration, sadness) was correlated with the strength 
of the BAS but not the BIS (Carver, 2004). Therefore, BAS response under conditions of 
both reward and the withdrawal of reward may be important in understanding how people 
cope with non-reward when reward is expected.
1.2. Current Study
Despite known relations between self-reported RST constructs and substance use, the 
physiological representation of BAS and BIS can provide incremental utility in 
understanding how this theory lends to our understanding of biological disorder. The current 
Derefinko et al. Page 3
Drug Alcohol Depend. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
study examines the utility of physiological responses during reward and frustrative non-
reward (hereafter described as extinction) stimuli in the prediction of later substance use. 
Substance use and physiological data were collected from 230 college freshmen at year 1, 
and substance use data was collected again at follow-up (year 3). Physiological measures of 
BIS/BAS collected during a reward and extinction task were used as predictors of future 
substance use at year 3, controlling for substance use at year 1. With only one existing study 
contributing to this literature (Brenner and Beauchaine, 2011), we sought to explore 
relations between physiological assessment of RST constructs and later substance use.
Although Beauchaine and colleagues’ work with children and young adolescents has shown 
associations between low BAS (lengthened PEP) responding during reward and childhood 
externalizing disorders (2001), we did not believe that this finding will replicate in an older, 
non-clinical sample given other previous work (Tomaka and Palacios-Esquivel, 1997). We 
hypothesized that shortened PEP responses during reward trials would indicate a stronger 
dopaminergic response to reward and would therefore be significant predictors of future 
alcohol, marijuana, and cigarette use. Due to emerging work targeting the role of BAS in 
frustrative non-reward responding (Carver, 2004; 2006), we hypothesized that shortened 
PEP response during extinction would be an equally significant predictor of later substance 
use outcomes. Although EDR fluctuations during extinction are believed to represent BIS 
functioning (Beauchaine, 2001), the lack of evidence associating BIS with substance use 
outcomes (Franken and Muris, 2006; Hundt et al., 2008) led us to hypothesize that EDR 
responses during extinction trials not be a predictor of later substance use.
2. Method
2.1. Participants
Participants (N = 230) were assessed yearly starting freshman year of college. The average 
age of participants at assessment was 18.49 years (SD = .72), and most were under 21 years 
of age (99%). Participants were recruited from introductory psychology courses and 
received course credit and monetary incentives for participation. Approximately 79% of 
participants identified as Caucasian, 13% African-American, and 8% as other.
“High risk” participants were over-recruited to ensure sufficient variability in substance use, 
and made up 26% of the sample. Students in introductory psychology courses were 
administered a screening questionnaire during a mass testing during the first two weeks of 
the semester. The screening measure assessed conduct problem behaviors that occurred prior 
to age 18 (e.g., stealing, lying, fighting). A composite was used to determine the distribution 
of scores for predicted substance use risk (calculated separately by gender). Those whose 
scores fell within the top 25% for their gender were specifically invited to participate 
through email.
2.2 Procedure and Attrition
Participants completed a substance use assessment and a physiological reward and extinction 
task at year 1. Substance use was assessed again at year 3. Of the original 230 individuals in 
the study, 218 had useable substance use data at year 1, 204 had usable physiological data at 
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year 1, and 105 had useable substance use data at year 3. Across all assessments, 95 had 
complete data to be used in individual analyses (53% female). Independent t-tests conducted 
for group demonstrated that the non-completers did not differ on any study variables from 
year 1 assessments (t scores ranged from .01 - 1.98; all p’s > .05).
2.3. Measures
2.3.1. Substance use—The Life History Calendar is a retrospective, computer-assisted 
interview method for collecting data on life events and behaviors (Caspi et al., 1996). 
Information was obtained regarding alcohol, marijuana, and cigarette use. Participants 
selected from six choices describing the frequency with which they used during each month 
of the past year (0 = did not use, 1 = once a month or less, 2 = once a week, 3 = 2 or 3 times 
a week, 4 = 4 or 5 times a week, 5 = every day). Data from year 1 represented our control 
variable in analyses (concurrent with the physiological assessment), and data from year 3 
represented future substance use.
2.3.2. Number Elimination Game task—All physiological responses were collected 
individually during the Number Elimination Game (NEG) task (see Beauchaine et al., 2001; 
Brenner and Beauchaine, 2011). Participants were seated in front of a computer in a 
temperature and humidity controlled testing room. Physiological signals were first collected 
during a 5-minute baseline where participants were asked to relax and visually fixate on a 
plus sign on the computer screen. Next, physiological responses continued to be collected 
during the NEG, a computerized repetitive response task, which included conditions of 
reward and extinction. During the task, single-digit, odd numbers (1, 3, 5, 7, or 9) were 
randomly presented on a computer screen. Participants were required to press the matching 
number on the keyboard to advance to the next stimuli. Incorrect responses were not 
recorded and did not result in penalties other than delay of advancing to the next number. 
The task was performed across five, 2-minute blocks, each separated by a 75 second 
intertrial baseline.
The first two blocks were reward conditions. During these trials, each correct response 
(pressing the key that matched the stimulus on the screen) resulted in an audio and visual 
reward signal, a reward of $0.02, and a presentation of a running total of money earned. 
Audio and visual reward cues were omitted for incorrect responses. The third block included 
60 seconds of reward and 60 seconds of nonreward (extinction), during which monetary 
incentives and audio signals were omitted following responses. The fourth block returned to 
the full 2 minutes of reward cues. The fifth block began with 60 seconds of extinction 
followed by 60 seconds of reward. Prior to the task, participants were informed that they 
could earn more money the faster they played and that they needed to continue responding to 
advance to the next reward stimuli even if the task no longer reacted to their responses.
2.3.3. Autonomic Measures—Autonomic activity (PEP, EDR) was measured using a 
BioNex system from Mindware Technologies (Gahanna, OH) and amplified using the 
appropriate module (BioNex Impedance Cardiograph and GSC, Model 50-371100-00). All 
acquired channels were sampled at a rate of 1000 Hz. Autonomic data were analyzed 
according to accepted scoring parameters using Mindware IMP (version 2.6) and EDA 
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software (version 2.6) (Mindware Technologies, Gahanna, OH), which included visual 
inspection and editing of artifacts.
Cardiac pre-ejection period (PEP), derived from electrocardiogram (ECG) and impedance 
cardiography (ICG), was assessed using standard lead II and tetrapolar placement of 
electrodes, respectively (Sherwood et al., 1990). PEP was quantified as the period of time in 
milliseconds between the onset of ventricular depolarization (Q-wave of ECG) and the 
opening of the aortic valve (B point of dZ/dt waveform from ICG; Lozano et al., 2007). PEP 
reflects myocardial contractility and is commonly used as an index of sympathetic cardiac 
control (Berntson et al. 2004). Lower PEP values (i.e., shorter cardiac latencies) indicate 
higher cardiac sympathetic activity.
Electrodermal response (EDR) data were collected using two disposable Ag–AgCl 
electrodes (Mindware Technologies, Model 93-0102-00) placed on the distal phalanges of 
the index and middle fingers of participants’ non-dominant hand. EDR was scored as the 
number of non-specific fluctuations in skin conductance exceeding 0.05 μS. Higher EDR 
values indicate greater sympathetic activity.
Mean PEP and EDR values were calculated by ensemble-averaging data in 30sec epochs for 
the following periods: Initial Baseline (final 2 minutes of an initial 5-minute baseline 
recording), Intertrial Baseline (75 second baseline period between trial blocks), and reward 
or extinction trials. To assess autonomic response during reward and extinction, change 
scores were calculated as difference scores between the averaged active trial responses and 
the Intertrial Baseline value immediately preceding. This yielded five reward response 
scores (one for each reward block), and two extinction response scores (see Figure 1).
3. Results
3.1. Preliminary Data Screening and Analyses
Table 1 provides raw scores across trials, in the order they were presented during the task, 
for PEP and EDR. As can be seen from Table 1, average PEP scores demonstrated a subtle 
rising trend during acclimation to the task, then varied responses above preceding baselines 
as competing contingencies of reward and extinction were introduced. Average raw EDR 
scores demonstrated a generally rising trend across the task, with little notable response 
during competing contingency trials. Graphical representations of these data are available in 
supplementary materials.
Figure 1 represents average changes scores for PEP and EDR across the course of the task. 
Change scores represent changes over baselines preceding the trials. Consistent with prior 
work (Tomaka and Palacios-Esquivel, 1997), PEP change scores demonstrated a rising trend 
during acclimation to reward, then a falling trend when competing contingencies were 
introduced. EDR change scores did not demonstrate a consistent trend.
Because lower PEP scores represent sympathetic excitation, PEP responses (change scores) 
were reverse coded for interpretability in all analyses (see Tables 2–6). All subsequent 
positive values for PEP and EDR represent high activation, and negative values represent 
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low activation of the BAS and BIS systems, respectively. Descriptive statistics are presented 
in Table 2. Consistent with the general population, substance use scores were positively 
skewed and exhibited more zeroes than would be compatible with normal regression models. 
Further tests revealed that the outcome distributions were Poisson-distributed (i.e., the mean 
was roughly equal to the standard deviation). Therefore, zero-inflated Poisson (ZIP) 
regression models were used in multivariate analyses.
Although EDR responses during reward trials were recorded and averaged as available 
material for figures, the lack of theory supporting the use of EDR during reward trials did 
not support its use as a representative construct of Reinforcement Sensitivity Theory in 
analyses (Beauchaine, 2001). Confirmation analyses were performed to ensure that EDR 
response during reward did not serve as a viable correlate or predictor of substance use. 
EDR response during reward did not emerge as a significant correlate or predictor in any of 
the analyses, and was therefore not included in the reporting of results.
Zero-order correlations between the study variables are presented in Table 3. To control for 
multiple analyses, probability was set at p < .01. There was a high, positive correlation 
between PEP responses during reward and extinction stimuli. All substance use variables at 
year 1 correlated with year 3 of the same substance.
3.2. Planned Hypothesis Tests
Nine zero-inflated Poisson (ZIP) regression models were fit in Mplus 7.2, regressing each of 
the year 3 substance use variables (alcohol, marijuana, and cigarettes) onto three sets of 
predictors: (1) substance use at year 1 and PEP response during reward (BAS activity), (2) 
substance use at year 1 and PEP response during extinction (possible BAS activity), and (3) 
substance use at year 1 and EDR response during extinction (BIS activity). Each of these 
models simultaneously estimates a logistic regression of the excessively zero-inflated part of 
the outcome variable on the predictors (the prediction of degree of abstention) and a 
regression of the continuous component of the outcome variable on the predictors 
(frequency of use). The intercept in all models represents estimated outcomes when all 
predictor values have a value of 0. In the logistic component of the model, this value 
represents the extent to which zero-inflation is affected (e.g., degree of abstention). All 
regression coefficients are presented as standardized values.
3.3. Alcohol Use
Results predicting year 3 alcohol use appear in Table 4. In each of the logistic model 
components, more frequent alcohol use at year 1 predicted a lower probability of 
contributing to the zero-inflation at year 3 (i.e., lesser degree of abstention). In continuous 
models, more frequent alcohol use at year 1 predicted more frequent alcohol use at year 3. 
Among the physiological predictors, low BAS activation during reward significantly 
predicted higher frequency of alcohol use at year 3. BAS responses and BIS responses 
during extinction did not predict future alcohol use.
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3.4. Marijuana Use
Results predicting year 3 marijuana use appear in Table 5. Greater frequency of marijuana 
use at year 1 was associated with a lower probability of contributing to the zero-inflation at 
year 3 (i.e., had a lesser degree of abstention) and greater frequency of marijuana smoking at 
year 3. Low BAS activation during both reward and extinction significantly predicted higher 
frequency of marijuana use at year 3. In addition, high BIS activation during extinction 
significantly predicted more frequent marijuana use at year 3.
3.5. Cigarette Use
Results predicting year 3 cigarette use appear in Table 6. Greater frequency of cigarette use 
at year 1 was associated with a lower probability of contributing to the zero-inflation at year 
3 (i.e., had a lesser degree of abstention) and greater frequency of cigarette smoking at year 
3. Consistent with alcohol and marijuana findings, results indicated that low BAS activation 
during extinction was associated with a lower likelihood of abstinence at year 3. BAS 
responses during reward and BIS responses during extinction did not predict future cigarette 
use.
4. Discussion
This study explored the possible contributions of physiologically assessed BAS and BIS to 
later alcohol, marijuana, and cigarette use. Results suggested relations opposite to those 
predicted for this non-clinical sample. Consistent with Brenner and Beauchaine (2011), 
individuals with low BAS during reward had significantly higher average frequency of use 
of alcohol and marijuana two years later. To test Carver’s (2006) hypothesis that BAS 
response during withdrawal of reward may represent an exaggerated BAS response, we 
explored PEP responses during extinction trials. Results indicated that low BAS responses 
during extinction trials were related to frequency of future marijuana use and a higher 
probability of cigarette use in general. Thus, BAS assessed during extinction may represent a 
similar pathway to that of responses during reward, and together, these constructs appear to 
characterize an individual who is under-reactive to the anticipation of reinforcement. 
Although not predicted, greater BIS response predicted future marijuana use. It appears that 
those sensitive to changing reward circumstances may be prone to more frequent marijuana 
use.
Based upon the current findings, multiple systems may be at work. First, these findings 
support the notion that those whose approach systems are under-responsive to reinforcement 
(and non-reward) use substances due to boredom-proneness or excitement seeking 
characteristics (Brenner and Beauchaine, 2011). This “reward deficit syndrome” has been 
posited as a risk factor in the development of substance use disorders (see Dawe and Loxton, 
2004). In fact, those prone to substance abuse have been found to have lower levels of 
dopamine concentration in neural pathways than comparison individuals, suggesting that 
they may be more receptive to the reinforcing effects of drugs and alcohol (Blum et al., 
2000). Further, as noted by Volkow and colleagues (2004), substance use itself may 
undermine the typical thresholds required for environmental events to activate dopamine 
release, thereby causing those with addiction to need more salient cues to provoke 
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dopaminergic activity. In this study, many participants were already using substances at year 
1. The low BAS activity recorded may be indicative of dopaminergic response already 
depleted by substance abuse.
The present results also suggest that different systems are at work during extinction. BIS 
activation is theorized to be mediated by the amygdala and septo-hippocampal systems 
(McNaughton and Corr, 2004), producing upsetting emotional states that may prime 
individuals to engage in unhealthy patterns of substance use (Baker et al., 2004). Although 
BIS/BAS activation is often explained in terms of negative and positive affect respectively 
(e.g., Heponiemi et al., 2003), others have argued that the relation between BIS/BAS and 
affective state is more complex and that activation of either system can result in negative or 
positive affect depending on input from a reflective feedback process (Carver, 2004; Carver 
and Scheier, 1998). Based upon dual significant results for marijuana use, it is possible that 
both dopamine activation deficits and amygdalar-mediated emotional upset during non-
reward work together to promote risk. We are not able to draw firm conclusions regarding 
the role of affect in these findings without direct assessment of affective state; however, it 
will be important for future research to explore the possible divergence between 
physiological/emotional responses to reward and extinction utilizing constructs grounded in 
personality and/or emotion. There was no measure of dopamine included in the current 
study; therefore, hypotheses regarding systems and possible treatment options are 
speculative.
The current work also speaks to the potential biological basis of traits (Zuckerman and 
Kuhlman, 2000) and suggests that intervening at both physiological and behavioral levels 
may be the most successful route to substance use prevention and treatment. Some have 
suggested a multiple systems approach that includes pharmacological and behavioral 
interventions for the treatment of drug addiction. (Volkow et al., 2003; Volkow et al., 2004). 
Recommended strategies could include the development of medications that either maintain 
stable concentrations of dopamine in the brain, adequately block dopaminergic receptors to 
eliminate the reinforcing, acute effects of drug use, or make the reception of drug aversive 
through sensitizing relevant receptors (Volkow et al., 2004). Some of these strategies have 
already demonstrated notable benefits (Ebbert et al., 2015; Rösner et al., 2010), but are not 
yet available across all substances of abuse. Alternatively, treatment may be directed at 
weakening conditional associations with drug effects or associated through behavioral 
conditioning and medications that disrupt memory processes in hippocampus and amygdala. 
As noted by Volkow and colleagues (2004), beta-blockers have been shown to interfere with 
conditioned responses to environmental reinforcers as well as to aversive stimuli, which is 
an effect mediated by the amygdala (Miranda et al., 2003). In addition, cognitive behavioral 
restructuring of thoughts and behavioral associated with drug cues may enhance the 
beneficial effects of medication.
There are several limitations to the current work, including retrospective substance use 
collection and the rather normative nature of the sample. While it is possible that different 
results may be found with more extensive substance use assessment within an exclusively 
substance abusing population, the current work provides an important start to this line of 
inquiry and presents clear evidence for the link between physiological responses to reward 
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and extinction and use of multiple substances. In addition, this work examines only one 
potential part of this relation: A directional link from physiological response to later 
substance use. Future work would do well to explore these relations in greater depth, 
including testing possible bi-directional associations between innate responses themselves, 
and between innate responses and substance use. It is likely that continued substance use 
reinforces these physiological responses, thereby creating an intractable reward-based 
physiology that contributes to addiction in indirect ways.
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Figure 1. 
Physiological change scores across reward and extinction trials.
Note. Scores represent response change over immediately preceding baseline score. All 
scores are standardized. PEP = Cardiac Pre-Ejection Period. PEP values represent changes in 
milliseconds. EDR = Electrodermal Response. EDR values represent non-specific 
fluctuations per minute.
Derefinko et al. Page 12
Drug Alcohol Depend. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Derefinko et al. Page 13
Table 1
Raw physiological scores across trials.
PEP PEP SD EDR EDR SD
Baseline 1 120.43 10.10 4.53 3.83
Trial 1: Reward 120.24 10.21 5.10 3.96
Baseline 2 120.49 10.21 5.00 3.93
Trial 2: Reward 120.76 9.74 5.08 3.94
Baseline 3 120.68 10.07 5.16 4.20
Trial 3: Reward 121.12 10.41 5.52 4.18
Trial 3: Extinction 121.47 9.90 5.51 4.13
Baseline 4 120.32 10.11 5.65 4.28
Trial 4: Reward 121.19 9.82 5.95 4.23
Baseline 5 120.34 10.06 5.81 4.48
Trial 5: Extinction 120.43 9.89 6.29 4.44
Trial 5: Reward 121.58 10.61 6.31 4.45
Note. PEP = Cardiac pre-ejection period, quantified as the period of time in milliseconds between the onset of ventricular depolarization (Q-wave) 
and the opening of the aortic valve (B point of dZ/dt waveform). EDR = Electrodermal response, scored as the number of non-specific fluctuations 
in skin conductance exceeding 0.05 μS. SD = standard deviation.
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Table 2
Means and Standard Deviations for study variables (N = 95).
Variable Mean SD % of sample
Age Year 1 18.92 .45
Female 53.2%
PEP Response to Reward −.09 2.97
PEP Response to Extinction −.34 2.89
EDR Response to Extinction .34 .47
Frequency of Alcohol Use Year 1 .82 .98
Frequency of Alcohol Use Year 3 .97 .94
Alcohol abstinence rate year 1 20.2
Alcohol abstinence rate year 3 11.6
Frequency of Marijuana Use Year 1 .42 .82
Frequency of Marijuana Use Year 3 .54 1.21
Marijuana abstinence rate year 1 60.0
Marijuana abstinence rate year 3 60.0
Frequency of Cigarette Use Year 1 .57 1.40
Frequency of Cigarette Use Year 3 .61 1.53
Cigarette abstinence rate year 1 82.1
Cigarette abstinence rate year 3 83.2
Note. PEP = Cardiac pre-ejection period response (change from baseline scores), reverse-coded such that higher numbers indicate greater 
sympathetic activity. EDR = Electrodermal response (change from baseline scores). SD = standard deviation. Substance Use variables represent 
average frequency of use. “Frequency” ranges from 0–5 and indicates the frequency with which participants used during each month of the past 
year (0 = did not use, 1 = once a month or less, 2 = once a week, 3 = 2 or 3 times a week, 4 = 4 or 5 times a week, 5 = every day).
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Table 4
Predictors of year 3 alcohol use.
Standardized B SEB
Model 1: Prediction of Year 3 Alcohol Use from Year 1 Alcohol Use and PEP Reward (N=94)
 Zero-Inflated: Contribution to Zero-Inflation/Abstinence
  Intercept −0.15 0.13
  Year 1 Alcohol Use
−0.85*** 0.09
  PEP - Reward 0.04 0.08
 Continuous: Frequency of Use
  Intercept 6.80*** 0.89
  Year 1 Alcohol Use 0.90*** 0.05
  PEP - Reward
−0.34** 0.10
Model 2: Prediction of Year 3 Alcohol Use from Year 1 Alcohol Use and PEP Extinction (N=94)
 Zero-Inflated: Contribution to Zero-Inflation/Abstinence
  Intercept −0.15 0.13
  Year 1 Alcohol Use
−0.85*** 0.08
  PEP – Extinction 0.06 0.08
 Continuous: Frequency of Use
  Intercept 7.27*** 0.96
  Year 1 Alcohol Use 0.96*** 0.03
  PEP - Extinction −0.15 0.10
Model 3: Prediction of Year 3 Alcohol Use from Year 1 Alcohol Use and EDR Extinction (N=89)
 Zero-Inflated: Contribution to Zero-Inflation/Abstinence
  Intercept −0.18 0.14
  Year 1 Alcohol Use
−0.09*** 0.01
  EDR – Extinction 0.19 0.15
 Continuous: Frequency of Use
  Intercept 7.72*** 1.04
  Year 1 Alcohol Use 0.10*** 0.01
  EDR - Extinction −0.19 0.24
Note. PEP = Cardiac pre-ejection period response (change from baseline scores), reverse-coded such that higher numbers indicate greater 
sympathetic activity. EDR = Electrodermal response (change from baseline scores). Significant coefficients presented in bold type.
**p < .01;
***p < .001.
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Table 5
Predictors of year 3 marijuana use.
Standardized B SEB
Model 1: Prediction of Year 3 Marijuana Use from Year 1 Marijuana Use and PEP Reward (N=94)
 Zero-Inflated: Contribution to Zero-Inflation/Abstinence
  Intercept 0.43*** 0.09
  Year 1 Marijuana Use
−0.67*** 0.11
  PEP - Reward 0.08 0.10
 Continuous: Frequency of Use
  Intercept 5.26*** 0.71
  Year 1 Marijuana Use 0.46*** 0.10
  PEP - Reward
−0.54*** 0.12
Model 2: Prediction of Year 3 Marijuana Use from Year 1 Marijuana Use and PEP Extinction (N=94)
 Zero-Inflated: Contribution to Zero-Inflation/Abstinence
  Intercept 0.43*** 0.09
  Year 1 Marijuana Use
−0.64*** 0.12
  PEP – Extinction 0.11 0.10
 Continuous: Frequency of Use
  Intercept 2.81*** 0.40
  Year 1 Marijuana Use 0.38*** 0.06
  PEP - Extinction
−0.82*** 0.04
Model 3: Prediction of Year 3 Marijuana Use from Year 1 Marijuana Use and EDR Extinction (N=89)
 Zero-Inflated: Contribution to Zero-Inflation/Abstinence
  Intercept 4.92*** 0.62
  Year 1 Marijuana Use
−0.68*** 0.11
  EDR – Extinction −0.02 0.10
 Continuous: Frequency of Use
  Intercept 0.45*** 0.12
  Year 1 Marijuana Use 0.90*** 0.05
  EDR - Extinction 0.44*** 0.08
Note. PEP = Cardiac pre-ejection period response (change from baseline scores), reverse-coded such that higher numbers indicate greater 
sympathetic activity. EDR = Electrodermal response (change from baseline scores). Significant coefficients presented in bold type.
**p < .01;
***p < .001.
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Table 6
Predictors of year 3 cigarette use.
Standardized B SEB
Model 1: Prediction of Year 3 Cigarette Use from Year 1 Cigarette Use and PEP Reward (N=95)
 Zero-Inflated: Contribution to Zero-Inflation/Abstinence
  Intercept 0.99*** 0.16
  Year 1 Cigarette Use
−0.74*** 0.08
  PEP Reward 0.26 0.11
 Continuous: Frequency of Use
  Intercept 13.69*** 3.28
  Year 1 Cigarette Use 0.88*** 0.14
  PEP Reward −0.32 0.27
Model 2: Prediction of Year 3 Cigarette Use from Year 1 Cigarette Use and PEP Extinction (N=95)
 Zero-Inflated: Contribution to Zero-Inflation/Abstinence
  Intercept 1.04*** 0.15
  Year 1 Cigarette Use
−0.71*** 0.08
  PEP Extinction 0.38** 0.12
 Continuous: Frequency of Use
  Intercept 14.78*** 3.48
  Year 1 Cigarette Use 0.96*** 0.09
  PEP Extinction −0.12 0.28
Model 3: Prediction of Year 3 Cigarette Use from Year 1 Cigarette Use and EDR Extinction (N=90)
 Zero-Inflated: Contribution to Zero-Inflation/Abstinence
  Intercept 1.01*** 0.19
  Year 1 Cigarette Use
−0.79*** 0.08
  EDR Extinction −0.05 0.14
 Continuous: Frequency of Use
  Intercept 15.05*** 3.01
  Year 1 Cigarette Use 1.00*** 0.02
  EDR Extinction −0.13 0.26
Note. PEP = Cardiac pre-ejection period response (change from baseline scores), reverse-coded such that higher numbers indicate greater 
sympathetic activity. EDR = Electrodermal response (change from baseline scores). Significant coefficients presented in bold type.
**p < .01;
***p < .001.
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